Abiopharma

🔍 DeWitt Adam (Executive)

Company: RB GLOBAL INC. (RBA)

Report Date: 2026-06-18

Detailed Transactions and Holdings:

• Acquired 25 shares of Dividend Equivalent Rights (DSUs) (Derivative)
  Date: 2026-06-18 | Code: A | equity_swap_involved: false | shares_owned_after: 580.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 6 shares of Dividend Equivalent Rights (2026 RSUs) (Derivative)
  Date: 2026-06-18 | Code: A | equity_swap_involved: false | shares_owned_after: 6.00 | transaction_form_type: 4 | Footnotes: F2, F2, F2

Footnotes:

• F1: The dividend equivalent rights accrued in respect of the reporting person's deferred share units, and become exercisable and payable concurrently with the deferred share units. Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share.
• F2: Each dividend equivalent right represents a contingent right to receive the economic equivalent of one RBA common share. The dividend equivalent rights accrued in respect of the 2026 grant of restricted share units (RSU), and become exercisable proportionately with the restricted share units to which they relate.